Henrik Bo Wiberg Larsson

Henrik Bo Wiberg Larsson

Clinical Professor

Member of:

  • Clinical Physiology and Nuclear Medicine


  1. 2018
  2. Published

    Permeability of the blood–brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing–remitting multiple sclerosis

    Cramer, S. P., Simonsen, H. J., Varatharaj, A., Galea, I., Frederiksen, J. L. & Larsson, Henrik Bo Wiberg, 2018, In: Annals of Neurology. 83, 5, p. 902-914

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 915094